Inhibition of TLR4-driven inflammation, which is a major mortality factor in trauma–hemorrhage patients, showed positive results in overcoming hemorrhage-induced cardiac dysfunction in vivo [85]. This evidence concerns the gene TLR4 and hemorrhage.